We are live on ! Find out more
CALA

Calithera Biosciences, Inc
CALA

Delisted

CALA was delisted on the 1st of February, 2023.

Back to rankings

94 hedge funds and large institutions have $382M invested in Calithera Biosciences, Inc in 2017 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 35 increasing their positions, 13 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

169% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 13

124% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 17

69% more capital invested

Capital invested by funds: $226M → $382M (+$157M)

27% more funds holding

Funds holding: 74 → 94 (+20)

60% less call options, than puts

Call options by funds: $1.22M | Put options by funds: $3.01M

Holders
94
Holders Change
+20
Holders Change %
+27.03%
% of All Funds
2.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
35
Reduced
13
Closed
17
Calls
$1.22M
Puts
$3.01M
Net Calls
-$1.8M
Net Calls Change
-$1.55M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$23.5M
2
State Street
State Street
Massachusetts
+$17.1M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$16.8M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$6.12M
5
AC
Ascend Capital
California
+$5.53M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$8.37M
2
SSA
Schonfeld Strategic Advisors
New York
-$4.63M
3
UOC
UBS O'Connor
Illinois
-$2.03M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.46M
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$1.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$67.9M +$6.12M +22,886 +11%
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$61.2M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$40.3M +$16.8M +62,745 +86%
Viking Global Investors
4
Viking Global Investors
Connecticut
$35.9M +$1.53M +5,735 +5%
BlackRock
5
BlackRock
New York
$30.6M +$23.5M +87,859 +579%
State Street
6
State Street
Massachusetts
$19.4M +$17.1M +64,114 +5,802%
Vanguard Group
7
Vanguard Group
Pennsylvania
$17.8M +$3.67M +13,725 +30%
Franklin Resources
8
Franklin Resources
California
$11.1M – – –
Citadel Advisors
9
Citadel Advisors
Florida
$8.48M +$381K +1,424 +5%
Lord, Abbett & Co
10
Lord, Abbett & Co
New Jersey
$7.39M +$2.64M +9,853 +66%
BIM
11
Bogle Investment Management
Massachusetts
$7.39M +$18.2K +68 +0.3%
AC
12
Ascend Capital
California
$6.14M +$5.53M +20,680 New
Northern Trust
13
Northern Trust
Illinois
$5.01M +$4.2M +15,722 +1,355%
CS
14
Candriam SCA
Luxembourg
$3.98M -$764K -2,855 -18%
ACM
15
Atika Capital Management
New York
$3.86M +$107K +400 +3%
IBT
16
International Biotechnology Trust
United Kingdom
$3.62M +$2.02M +7,535 +162%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$3.47M +$1.7M +6,340 +118%
Acadian Asset Management
18
Acadian Asset Management
Massachusetts
$3.47M +$2.69M +10,047 +609%
Millennium Management
19
Millennium Management
New York
$3.41M +$2.06M +7,713 +205%
AG
20
Artal Group
Luxembourg
$2.97M +$2.67M +10,000 New
TCIM
21
TIAA CREF Investment Management
New York
$2.73M +$2.46M +9,181 New
Goldman Sachs
22
Goldman Sachs
New York
$1.92M -$64.2K -240 -4%
BCM
23
Bridgeway Capital Management
Texas
$1.9M – – –
Morgan Stanley
24
Morgan Stanley
New York
$1.76M +$272K +1,016 +21%
American Century Companies
25
American Century Companies
Missouri
$1.69M +$1.52M +5,697 New
1
2 3 4 5

CALA Hedge Fund Activity: Q2 2017 in Review

94 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q2 2017, worth a combined $382M — up 69% from $226M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new CALA positions and 17 closed out — a net gain of 21 holders — while 35 added to existing stakes and 13 trimmed.

The largest buyer was BlackRock, adding an estimated $23.5M. The largest seller was RA Capital Management, exiting entirely with an estimated $8.37M sold.

  • 94 institutional investors held Calithera Biosciences, Inc (CALA) as of Q2 2017, up from 74 in Q1 2017.
  • Funds reported $382M of Calithera Biosciences, Inc stock for Q2 2017, up 69% quarter-over-quarter.
  • 38 funds opened new Calithera Biosciences, Inc positions in Q2 2017 and 17 closed out, a net change of +21 holders.
  • The largest Calithera Biosciences, Inc buyer in Q2 2017 was BlackRock, an estimated $23.5M added.
  • The largest Calithera Biosciences, Inc seller in Q2 2017 was RA Capital Management, an estimated $8.37M sold.

Based on aggregated 13F filings for Q2 2017.